Lautermann J, McLaren J, Schacht J
Kresge Hearing Research Institute, Department of Otolaryngology, University of Michigan, Ann Arbor 48109-0506, USA.
Hear Res. 1995 Jun;86(1-2):15-24. doi: 10.1016/0378-5955(95)00049-a.
This study demonstrates that gentamicin ototoxicity depends on dietary factors and correlates with tissue glutathione levels. After 15 days of gentamicin injections (100 mg/kg/day s.c.) guinea pigs on a regular protein diet (18.5% protein) had an average hearing loss of 9 dB at 3 kHz, 31 dB at 8 kHz and 42 dB at 18 kHz. Guinea pigs on a 7% protein diet showed an increased hearing loss of 52 dB at 3 kHz, 63 dB at 8 kHz and 74 dB at 18 kHz. Supplementing the low protein diet with either essential or sulfur-containing amino acids did not protect against gentamicin ototoxicity. Glutathione levels in the cochlear sensory epithelium were decreased in animals on a low protein diet and could be restored to normal by oral administration of glutathione monoethyl ester (1.2 g/kg/day) in combination with vitamin C (100 mg/kg/day). Glutathione supplementation significantly reduced the magnitude of hearing loss in the low protein diet group at all frequencies (43 dB reduction at 3 kHz, 27 dB reduction at 8 kHz and 21 dB reduction at 18 kHz). In animals on a full protein diet, dietary glutathione neither increased cochlear glutathione levels nor attenuated hearing loss. Serum gentamicin levels did not differ between animals on the various diets with or without glutathione supplement. These results suggest that gentamicin toxicity and detoxifying mechanisms are affected by the metabolic state of the animal and the glutathione content of the tissue. Thus, compounds that could potentially protect against gentamicin ototoxicity may be more correctly assessed in animal models of deficient nutritional states in which endogenous detoxifying mechanisms are compromised. This animal model might also be more realistically related to the clinical situation of a critically ill patient receiving gentamicin treatment.
本研究表明,庆大霉素耳毒性取决于饮食因素,并与组织谷胱甘肽水平相关。在进行15天的庆大霉素注射(100毫克/千克/天,皮下注射)后,食用常规蛋白质饮食(蛋白质含量为18.5%)的豚鼠在3千赫时平均听力损失为9分贝,在8千赫时为31分贝,在18千赫时为42分贝。食用7%蛋白质饮食的豚鼠在3千赫时听力损失增加至52分贝,在8千赫时为63分贝,在18千赫时为74分贝。用必需氨基酸或含硫氨基酸补充低蛋白饮食并不能预防庆大霉素耳毒性。低蛋白饮食动物的耳蜗感觉上皮中的谷胱甘肽水平降低,通过口服谷胱甘肽单乙酯(1.2克/千克/天)与维生素C(100毫克/千克/天)联合使用可恢复正常。补充谷胱甘肽显著降低了低蛋白饮食组在所有频率下的听力损失幅度(3千赫时降低43分贝,8千赫时降低27分贝,18千赫时降低21分贝)。在食用全蛋白饮食的动物中,饮食中的谷胱甘肽既没有增加耳蜗谷胱甘肽水平,也没有减轻听力损失。在有或没有补充谷胱甘肽的情况下,不同饮食的动物血清庆大霉素水平没有差异。这些结果表明,庆大霉素毒性和解毒机制受动物代谢状态和组织谷胱甘肽含量的影响。因此,在营养状态不足的动物模型中,内源性解毒机制受损时,可能更准确地评估具有潜在预防庆大霉素耳毒性作用的化合物。这种动物模型可能也更现实地反映了接受庆大霉素治疗的重症患者的临床情况。